STOCK TITAN

[Form 4] Life360, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Chris Hulls, a director of Life360, Inc. (LIF), reports a non‑market transaction on 09/04/2025 in which 7,152 shares of common stock were withheld by the issuer at a per‑share price of $86.65 to satisfy income tax withholding related to the vesting and net settlement of previously reported restricted stock units. After this withholding, the Reporting Person beneficially owns 476,678 shares (this total includes common stock and shares underlying CDIs converted on a 1:3 common stock to CDI ratio). The filing notes 137,853 restricted stock units previously granted and identifies holdings reported indirectly: 195,312 shares held by each of three named irrevocable trusts and 1,846 shares representing the Reporting Person’s proportionate interest in ICCA Labs, LLC. The Form 4 was signed by an attorney‑in‑fact on 09/08/2025.

Chris Hulls, membro del consiglio di amministrazione di Life360, Inc. (LIF), segnala una operazione non di mercato avvenuta il 04/09/2025 in cui l'emittente ha trattenuto 7.152 azioni ordinarie al prezzo di $86,65 per azione per soddisfare le ritenute fiscali dovute al vesting e al regolamento netto di unità di azioni ristrette già comunicate. Dopo questa trattenuta, la persona che segnala detiene di diritto 476.678 azioni (totale che comprende azioni ordinarie e ADR/CDI convertiti con rapporto 1:3 azioni ordinarie:CDI). Il documento indica inoltre 137.853 unità di azioni ristrette precedentemente assegnate e riporta partecipazioni detenute indirettamente: 195.312 azioni detenute da ciascuno di tre trust irrevocabili nominati e 1.846 azioni che rappresentano la quota proporzionale della persona che segnala in ICCA Labs, LLC. Il Modulo 4 è stato firmato da un procuratore il 08/09/2025.

Chris Hulls, director de Life360, Inc. (LIF), informa una transacción no mercantil fechada el 04/09/2025 en la que el emisor retuvo 7.152 acciones ordinarias a $86,65 por acción para cubrir las retenciones fiscales relacionadas con el vesting y la liquidación neta de unidades de acciones restringidas previamente comunicadas. Tras esta retención, la persona informante posee de manera beneficiosa 476.678 acciones (esta cifra incluye acciones ordinarias y accciones subyacentes convertidas a CDIs con una proporción 1:3 acciones ordinarias:CDI). La presentación señala además 137.853 unidades de acciones restringidas concedidas anteriormente e identifica tenencias reportadas indirectamente: 195.312 acciones en poder de cada uno de tres fideicomisos irrevocables nombrados y 1.846 acciones que representan el interés proporcional de la persona informante en ICCA Labs, LLC. El Formulario 4 fue firmado por un apoderado el 08/09/2025.

크리스 헐스(Chris Hulls), Life360, Inc. (LIF) 이사로서 2025년 9월 4일자로 비시장 거래를 신고했으며, 발행사가 이전에 보고된 제한주식단위(RSU)의 베스팅 및 순결제를 위한 소득세 원천징수 목적으로 7,152주의 보통주를 주당 $86.65에 원천징수했습니다. 해당 원천징수 후 보고인은 476,678주를 실질적으로 보유하게 되었습니다(이 합계에는 보통주 및 1:3 비율로 보통주 대비 CDI로 전환된 주식이 포함됩니다). 서류에는 이전에 부여된 137,853개의 제한주식단위가 명시되어 있으며, 간접 보유로 보고된 지분으로는 각각 세 명의 지정된 불가역 신탁이 보유한 195,312주와 보고인의 ICCA Labs, LLC에 대한 비례 지분을 나타내는 1,846주가 포함됩니다. Form 4는 2025년 9월 8일 대리인이 서명했습니다.

Chris Hulls, administrateur de Life360, Inc. (LIF), déclare une opération hors marché datée du 04/09/2025 au cours de laquelle l'émetteur a retenu 7 152 actions ordinaires au prix de 86,65 $ par action pour couvrir les retenues fiscales liées au vesting et au règlement net d'unités d'actions restreintes précédemment signalées. Après cette retenue, la personne déclarante détient de manière bénéficiaire 476 678 actions (ce total comprend les actions ordinaires et les actions sous‑jacentes converties en CDI selon un ratio de 1:3 actions ordinaires:CDI). La déclaration indique en outre 137 853 unités d'actions restreintes antérieurement attribuées et identifie des participations détenues indirectement : 195 312 actions détenues par chacun de trois trusts irrévocables nommés et 1 846 actions représentant la part proportionnelle de la personne déclarante dans ICCA Labs, LLC. Le formulaire 4 a été signé par un mandataire le 08/09/2025.

Chris Hulls, Direktor von Life360, Inc. (LIF), meldet eine Nicht-Marktransaktion vom 04.09.2025, bei der der Emittent 7.152 Stammaktien zum Preis von $86,65 pro Aktie einbehalten hat, um die einkommensteuerlichen Abzüge im Zusammenhang mit dem Vesting und der Nettoberichtigung zuvor gemeldeter Restricted Stock Units zu erfüllen. Nach diesem Einbehalt besitzt die meldende Person wirtschaftlich 476.678 Aktien (diese Summe umfasst Stammaktien sowie Aktien, die in CDIs im Verhältnis 1:3 Stammaktie:CDI umgewandelt wurden). Die Einreichung verzeichnet außerdem zuvor gewährte 137.853 Restricted Stock Units und nennt indirekt gehaltene Bestände: jeweils 195.312 Aktien gehalten von drei benannten unwiderruflichen Trusts sowie 1.846 Aktien, die den anteiligen Anteil der meldenden Person an ICCA Labs, LLC darstellen. Das Formular 4 wurde am 08.09.2025 von einem Bevollmächtigten unterschrieben.

Positive
  • Transaction was administrative (tax withholding) rather than an open‑market sale, indicating no immediate insider sell signal
  • Full beneficial ownership disclosed, including indirect holdings and CDIs, improving transparency
Negative
  • 7,152 shares were withheld, reducing the Reporting Person's direct share count by that amount
  • Some CDIs remain subject to a lock‑up agreement, which may limit liquidity of those holdings

Insights

TL;DR: Director withheld 7,152 shares for tax on RSU vesting; total beneficial ownership remains materially disclosed at 476,678 shares.

The reported transaction is a non‑market, administrative remittance of shares to satisfy tax obligations tied to RSU vesting rather than an open‑market sale, so it does not signal a liquidity event or change in voting intention. The filing clarifies the composition of beneficial ownership, including CDIs converted at a 1:3 ratio and sizable holdings through irrevocable trusts and an LLC interest. For investors, this preserves transparency about insider ownership but carries no direct cash flow or market impact beyond the routine reduction in outstanding shares held by the insider.

TL;DR: Routine tax withholding on vested RSUs; reporting is consistent with Section 16 requirements and shows indirect trust holdings.

The Form 4 properly discloses a Code F transaction (withholding to satisfy tax withholding on vested equity). It also identifies indirect holdings via multiple irrevocable trusts and an LLC, which is important for understanding control and potential lock‑up status (the filing notes certain CDIs remain subject to a lock‑up). Signature by an attorney‑in‑fact and single filer status are standard administrative details. Overall, the filing reflects standard insider compensation mechanics rather than governance concerns or executive departures.

Chris Hulls, membro del consiglio di amministrazione di Life360, Inc. (LIF), segnala una operazione non di mercato avvenuta il 04/09/2025 in cui l'emittente ha trattenuto 7.152 azioni ordinarie al prezzo di $86,65 per azione per soddisfare le ritenute fiscali dovute al vesting e al regolamento netto di unità di azioni ristrette già comunicate. Dopo questa trattenuta, la persona che segnala detiene di diritto 476.678 azioni (totale che comprende azioni ordinarie e ADR/CDI convertiti con rapporto 1:3 azioni ordinarie:CDI). Il documento indica inoltre 137.853 unità di azioni ristrette precedentemente assegnate e riporta partecipazioni detenute indirettamente: 195.312 azioni detenute da ciascuno di tre trust irrevocabili nominati e 1.846 azioni che rappresentano la quota proporzionale della persona che segnala in ICCA Labs, LLC. Il Modulo 4 è stato firmato da un procuratore il 08/09/2025.

Chris Hulls, director de Life360, Inc. (LIF), informa una transacción no mercantil fechada el 04/09/2025 en la que el emisor retuvo 7.152 acciones ordinarias a $86,65 por acción para cubrir las retenciones fiscales relacionadas con el vesting y la liquidación neta de unidades de acciones restringidas previamente comunicadas. Tras esta retención, la persona informante posee de manera beneficiosa 476.678 acciones (esta cifra incluye acciones ordinarias y accciones subyacentes convertidas a CDIs con una proporción 1:3 acciones ordinarias:CDI). La presentación señala además 137.853 unidades de acciones restringidas concedidas anteriormente e identifica tenencias reportadas indirectamente: 195.312 acciones en poder de cada uno de tres fideicomisos irrevocables nombrados y 1.846 acciones que representan el interés proporcional de la persona informante en ICCA Labs, LLC. El Formulario 4 fue firmado por un apoderado el 08/09/2025.

크리스 헐스(Chris Hulls), Life360, Inc. (LIF) 이사로서 2025년 9월 4일자로 비시장 거래를 신고했으며, 발행사가 이전에 보고된 제한주식단위(RSU)의 베스팅 및 순결제를 위한 소득세 원천징수 목적으로 7,152주의 보통주를 주당 $86.65에 원천징수했습니다. 해당 원천징수 후 보고인은 476,678주를 실질적으로 보유하게 되었습니다(이 합계에는 보통주 및 1:3 비율로 보통주 대비 CDI로 전환된 주식이 포함됩니다). 서류에는 이전에 부여된 137,853개의 제한주식단위가 명시되어 있으며, 간접 보유로 보고된 지분으로는 각각 세 명의 지정된 불가역 신탁이 보유한 195,312주와 보고인의 ICCA Labs, LLC에 대한 비례 지분을 나타내는 1,846주가 포함됩니다. Form 4는 2025년 9월 8일 대리인이 서명했습니다.

Chris Hulls, administrateur de Life360, Inc. (LIF), déclare une opération hors marché datée du 04/09/2025 au cours de laquelle l'émetteur a retenu 7 152 actions ordinaires au prix de 86,65 $ par action pour couvrir les retenues fiscales liées au vesting et au règlement net d'unités d'actions restreintes précédemment signalées. Après cette retenue, la personne déclarante détient de manière bénéficiaire 476 678 actions (ce total comprend les actions ordinaires et les actions sous‑jacentes converties en CDI selon un ratio de 1:3 actions ordinaires:CDI). La déclaration indique en outre 137 853 unités d'actions restreintes antérieurement attribuées et identifie des participations détenues indirectement : 195 312 actions détenues par chacun de trois trusts irrévocables nommés et 1 846 actions représentant la part proportionnelle de la personne déclarante dans ICCA Labs, LLC. Le formulaire 4 a été signé par un mandataire le 08/09/2025.

Chris Hulls, Direktor von Life360, Inc. (LIF), meldet eine Nicht-Marktransaktion vom 04.09.2025, bei der der Emittent 7.152 Stammaktien zum Preis von $86,65 pro Aktie einbehalten hat, um die einkommensteuerlichen Abzüge im Zusammenhang mit dem Vesting und der Nettoberichtigung zuvor gemeldeter Restricted Stock Units zu erfüllen. Nach diesem Einbehalt besitzt die meldende Person wirtschaftlich 476.678 Aktien (diese Summe umfasst Stammaktien sowie Aktien, die in CDIs im Verhältnis 1:3 Stammaktie:CDI umgewandelt wurden). Die Einreichung verzeichnet außerdem zuvor gewährte 137.853 Restricted Stock Units und nennt indirekt gehaltene Bestände: jeweils 195.312 Aktien gehalten von drei benannten unwiderruflichen Trusts sowie 1.846 Aktien, die den anteiligen Anteil der meldenden Person an ICCA Labs, LLC darstellen. Das Formular 4 wurde am 08.09.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hulls Chris

(Last) (First) (Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310

(Street)
SAN MATEO CA 94403

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/04/2025 F(1) 7,152 D $86.65 476,678(2)(3) D
Common Stock 195,312(4) I Held by the Robin Hulls 2023 Irrevocable Trust
Common Stock 195,312(4) I Held by the Rose Hulls 2023 Irrevocable Trust
Common Stock 195,312(4) I Held by the Mckenzie Hulls 2023 Irrevocable Trust
Common Stock 1,846(5) I Held by ICCA Labs, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
2. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
3. Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
4. Represents shares of the Issuer's common stock underlying 585,938 CDIs, which remain subject to a lock-up agreement.
5. The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
Remarks:
/s/ Allison Chang, Attorney-in-Fact 09/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Life360 director Chris Hulls report on Form 4 (LIF)?

He reported withholding of 7,152 shares on 09/04/2025 at $86.65 per share to satisfy income tax withholding related to vested RSUs.

Does the Form 4 indicate an open‑market sale by Chris Hulls (LIF)?

No. The filing states the shares were withheld by the issuer to satisfy tax obligations from RSU vesting, not sold in the market.

How many shares does Chris Hulls beneficially own after the transaction?

476,678 shares are reported as beneficially owned following the reported transaction, which includes common stock and shares underlying CDIs converted on a 1:3 ratio.

What RSU information is disclosed in the Form 4 for LIF?

137,853 restricted stock units previously granted are included in the filing as RSUs that represent contingent rights to receive common stock upon vesting.

Are there indirect holdings disclosed for Chris Hulls?

Yes. The filing lists 195,312 shares held by each of three named irrevocable trusts and 1,846 shares representing his proportionate interest in ICCA Labs, LLC.
Life360 Inc

NASDAQ:LIF

LIF Rankings

LIF Latest News

LIF Latest SEC Filings

LIF Stock Data

8.00B
61.50M
2.25%
26.78%
4.63%
Software - Application
Services-computer Processing & Data Preparation
Link
United States
SAN MATEO